Loading Events

« All Events

  • This event has passed.

Solve M.E. and BIO co-host “Long Covid: What Will It Take To Accelerate Therapeutic Progress?”

February 21, 2023 @ 10:00 am - 1:00 pm UTC+8

Solve M.E. and The Biotechnology Innovation Organization (BIO) will co-host a three-hour virtual event “Long Covid: What Will It Take to Accelerate Therapeutic Progress?” on Tuesday, February 21 from 10:00 AM – 1:00 PM PT (1:00 – 4:00 PM ET). 

Our goal is to convene stakeholders to advance research and development to diagnose and treat Long Covid, ME/CFS, and other post-infection diseases. By increasing awareness among drug developers to the unmet needs of our communities, we hope to inspire these industry players to study these diseases and create therapeutic breakthroughs. 

The session will establish a knowledge base of emerging research in Long Covid and existing body of data in other post-infection diseases (such as myalgic encephalomyelitis/chronic fatigue syndrome, dysautonomia, mast cell activation, and others). The session also will feature solution-oriented perspectives from government, academic, and industry researchers, patient groups, funding sources, and policymakers. 

Hosts:

  • Oved Amitay, R.Ph., M.Sc., President and CEO of Solve M.E. Christopher Austin, MD, CEO-Partner, Flagship Pioneering
  • Cartier Esham, PhD, Chief Science Officer, Biotechnology Innovation Organization (BIO)

Opening Remarks:

  • US Senator, Tim Kaine
  • Rachel L. Levine, M.D., Admiral, U.S. Public Health Service, U.S. Department of Health and Human Services

Speakers:

  • Akiko Iwasaki, PhD, Sterling Professor of Immunobiology (Microbial Diseases), Yale School of Medicine
  • Bruce Patterson, MD, CEO & Founder, IncellDx
  • Christopher Austin, MD, CEO-Partner, Flagship Pioneering
  • David Putrino, PhD, Associate Professor, Rehabilitation and Human
  • Julie Gerberding, MD, MPH, CEO, Foundation for the National Institutes of Health
  • Katie Bach, MBA, Nonresident Senior Fellow,Brookings Institution
  • Lisa McCorkell, MPP, Co-Founder, Patient-Led Research Collaborative
  • Margaret Koziel, MD, SVP, Chief Medical Officer, Axcella Therapeutics
  • Priti Patel, MD, MPH, Senior Advisor for Post-COVID Conditions, Centers for Disease Control and Prevention
  • Rachel L. Levine, M.D., Admiral, U.S. Public Health Service, U.S. Department of Health and Human Services
  • Seth Lederman, MD, Co-Founder, CEO & Chairman, Tonix Pharmaceuticals
  • Thomas Equels, M.S., J.D., CEO, AIM Immunotech
  • Walter Koroshetz, MD, Director, National Institute of Neurological Disorders and Stroke (NINDS)

Solve M.E. is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.

BIO is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries.

Make Your Voice Heard in the Halls of Power!

Sign up for virtual Advocacy Week April 15-19

Transform your data into clinical breakthroughs!

Join Solve Together today

Skip to content